Clearside Biomedical (NSDQ:CLSD) said today that it finished enrollment for the Phase 1/2 study of CLS-TA in patients with diabetic macular edema. The Hulk trial is designed to evaluate the safety and efficacy of a suprachoroidal injection of its suspension formulation of a corticosteroid, triamcinolone acetonide, with and without an intravitreal injection of Eylea in […]
Pharmaceutical
Teva launches AirDuo RespiClick, generic inhaled asthma therapies
Teva Pharmaceutical (NYSE:TEVA) said today that it launched the AirDuo RespiClick inhalation therapy and its authorized generic in the U.S. for asthma patients who are uncontrolled on an inhaled corticosteroid. AirDuo RespiClick and the generic are fixed-dose combination therapies contained fluticasone propionate and salmeterol – the same active ingredients as Advair. The therapies are delivered […]
Targeted drug delivery system releases chemo drug for 40 days
Researchers at Case Western Reserve University have developed a targeted drug delivery system that is triggered by the acidic environment around a tumor. The system delivers chemotherapy to the tumor for 40 days and doesn’t affect healthy tissues, according to a preclinical study published in Experimental Biology and Medicine. Get the full story at our sister site, Drug […]
First European patients treated with BTG’s drug-eluting bead
BTG (LON:BTG) said today that the 1st batch of patients in the European Union were treated with its DC Bead Lumi radiopaque drug-eluting bead. Two patients were treated for hepatocellular carcinoma and 1 patient was treated for malignant colorectal cancer metastasized to the liver. The bead, which is the 1st commercially available radiopaque drug-eluting bead in […]
Parvus inks exclusive license with Novartis for T1D nanomedicine
Parvus Therapeutics said today that it signed an exclusive worldwide license and collaboration deal with Novartis (NYSE:NVS) for its type 1 diabetes nanodrug, Navacim. The therapeutic candidate is made up of iron oxide nanoparticles coated with a peptide derived from a pancreatic autoantigen, according to Parvus. Navacims are the 1st biopharmaceuticals to restore immune tolerance through […]
Milestone Scientific lands marketing clearance in Saudi Arabia, Australia
Milestone Scientific (NYSE:MLSS) shares rose today after the company said it won marketing clearance in Saudi Arabia, weeks after winning a regulatory nod in Australia for its epidural and intra-articular instruments. The company’s CompuFlo Epidural instrument uses dynamic pressure sensing to help anesthesiologists correctly identify the epidural space and significantly reduce complications, according to Milestone. The […]
Imprimis, Precision Lens sign marketing and sales agreement
Imprimis Pharmaceuticals (NSDQ:IMMY) said today that it signed a 3-year exclusive sales agreement with Precision Lens. According to the deal, Precision Lens plans to deploy a sales team to expand Imprimis’ ophthalmic portfolio in 13 states across the U.S. Midwest. Precision Lens said it will sell San Diego-based Imprimis’ Dropless Therapy, LessDrops combination eye drops […]
Livongo, Glytec ink deal for electronic diabetes management solution
Digital Health company Livongo Health said today that it is partnering with Glytec to develop a diabetes management solution that includes insulin titration. The companies plan to expand Glytec’s eGlycemic Management System to improve health outcomes in patients with diabetes. Glytec touted that its suite of FDA-cleared dosing algorithms for IV, subcutaneous and pediatric insulin […]
BD warns customers about injury reports from Eclipse needle
Becton Dickinson warned customers and business partners that it has received reports of needlestick injury for its BD Eclipse needle, used in transfusion procedures, causing patients to contact their personal injury lawyer for help. Arrow International, which uses BD’s Eclipse needle devices in certain products, wrote to its customers today to inform them of the […]
Sanofi promotes Sibold to exec VP of Sanofi Genzyme | Personnel Moves – April 13, 2017
Sanofi (NYSE:SNY) said at the start of April that it promoted Bill Sibold to exec VP of Sanofi Genzyme, effective July 1, 2017. Sibold succeeds Dr. David Meeker, who is slated to leave the company at the end of June. Sibold is the head of Sanofi Genzyme’s global multiple sclerosis, oncology and immunology organization. He […]
Nanoparticle nasal spray targets drugs to the brain
Drug delivery to the brain could 1 day be as simple as a sniff, according to engineers at Washington University that developed a new nanoparticle-based delivery technique. “This would be a nanoparticle nasal spray, and the delivery system could allow a therapeutic dose of medicine to reach the brain within 30 minutes to one hour,” […]